Humane Technologies Limited (HTL) has announced that it has successfully developed a prototype for the next generation of its microbial growth measurement device, the MicrobeMeter.
A discovery by University of Warwick spin-out company Cytecom offers a new technology for detecting bacteria in minutes by ‘zapping’ the bacteria with electricity.
Stoli Catalysts, has been awarded €1.2m from the European Innovation Council (EIC) SME Instrument scheme to design, build and test a small-scale pilot plant to make medicines, vitamins and food supplements at much lower cost and more sustainably using its patented continuous flow catalytic reactor technology.
A new cryoprotectant polymer that dramatically improves the freezing of cells, has been discovered by researchers at the University of Warwick. The new polymers can reduce the amount of organic solvent required in cryopreservation (freezing cells) as well as giving more and healthier cells after thawing. Findings may help reduce cost and improve distribution of cells for cell-based therapies, diagnostics and research
Medherent Ltd, developer of the TEPI© Patch drug delivery technology, has appointed John Burt as its new CEO
Verdel Instruments Ltd - a spin-out company of the University of Warwick UK – has developed new disruptive two-dimensional mass spectrometry (2DMS) technology and raised seed investment of over £230,000 from Longwall Ventures and Innovate UK.
Warwick University spinout, Spectra Analytics, has been awarded £1m by Innovate UK to improve Primary Care using AI
Medherant Limited, the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment from Mercia Technologies PLC.
The Faculty of Social Sciences and Warwick Ventures celebrated the conclusion of the first-ever VIBE (Venture Into Business Engagement) programme; a newly created programme to help Social Sciences researchers engage with business.
Innovation to Commercialisation of University Research (ICURe) is designed to move ideas and innovation out of universities and into the marketplace, where they will have the greatest impact. If you are an Early Career Researcher and think your research might have commercial potential, find out how to apply here.